<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://jem.rupress.org">
<title>Journal of Experimental Medicine Articles</title>
<link>http://jem.rupress.org</link>
<description>Journal of Experimental Medicine RSS feed -- recent Articles articles</description>
<prism:eIssn>1540-9538</prism:eIssn>
<prism:publicationName>Journal of Experimental Medicine</prism:publicationName>
<prism:issn>0022-1007</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2613?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2625?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2641?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2659?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2671?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2685?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2701?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2717?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2735?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2747?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2761?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2779?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2795?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2809?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2823?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/12/2837?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2351?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2365?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2381?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2397?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2407?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2417?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2429?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2441?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2455?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2469?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2483?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2497?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2511?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2527?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2543?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/11/2557?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2161?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2179?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2191?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2205?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2221?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2235?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2253?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2271?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/10/2285?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1883?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1899?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1913?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1929?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1941?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1957?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1971?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1983?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/1995?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/2013?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/2027?rss=1" />
  <rdf:li rdf:resource="http://jem.rupress.org/cgi/content/short/206/9/2037?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://jem.rupress.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://jem.rupress.org/icons/banner/title.gif">
<title>Journal of Experimental Medicine</title>
<url>http://jem.rupress.org/icons/banner/title.gif</url>
<link>http://jem.rupress.org</link>
</image>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2613?rss=1">
<title><![CDATA[Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2613?rss=1</link>
<description><![CDATA[
<p>Both class switch recombination (CSR) and somatic hypermutation (SHM) require transcription and the trans-acting factor activation-induced cytidine deaminase (AID), and must be up-regulated during antigen-dependent differentiation of B lymphocytes. To test the role of the heavy chain 3' enhancers in both CSR and SHM, we used a BAC transgene of the entire heavy chain constant region locus. Using Cre-loxP recombination to delete a 28-kb region that contains the four known 3' heavy chain enhancers, we isolated lines of BAC transgenic mice with an intact heavy chain locus and paired lines in the same chromosomal insertion site lacking the 3' enhancers. Intact heavy chain transgenes undergo CSR to all heavy chain genes and mutate their transgenic VDJ exon. In paired transgenes lacking the 3' enhancer region, CSR to most heavy chain genes is reduced to ~1% of the levels for intact heavy chain loci; SHM is also reduced. Finally, we find that in B cells with a transgene lacking the 3' enhancers, interchromosomal recombination between the transgenic VDJ exon and the endogenous heavy chain C genes is more easily detected than CSR within the transgene.</p>
]]></description>
<dc:creator><![CDATA[Dunnick, W. A., Collins, J. T., Shi, J., Westfield, G., Fontaine, C., Hakimpour, P., Papavasiliou, F. N.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:36 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091280</dc:identifier>
<dc:title><![CDATA[Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2613</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2623</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2613</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2625?rss=1">
<title><![CDATA[Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2625?rss=1</link>
<description><![CDATA[
<p>The H2AX core histone variant is phosphorylated in chromatin around DNA double strand breaks (DSBs) and functions through unknown mechanisms to suppress antigen receptor locus translocations during V(D)J recombination. Formation of chromosomal coding joins and suppression of translocations involves the ataxia telangiectasia mutated and DNA-dependent protein kinase catalytic subunit serine/threonine kinases, each of which phosphorylates H2AX along cleaved antigen receptor loci. Using Abelson transformed pre&ndash;B cell lines, we find that H2AX is not required for coding join formation within chromosomal V(D)J recombination substrates. Yet we show that H2AX is phosphorylated along cleaved Ig DNA strands and prevents their separation in G1 phase cells and their progression into chromosome breaks and translocations after cellular proliferation. We also show that H2AX prevents chromosome breaks emanating from unrepaired RAG endonuclease-generated TCR-/ locus coding ends in primary thymocytes. Our data indicate that histone H2AX suppresses translocations during V(D)J recombination by creating chromatin modifications that stabilize disrupted antigen receptor locus DNA strands to prevent their irreversible dissociation. We propose that such H2AX-dependent mechanisms could function at additional chromosomal locations to facilitate the joining of DNA ends generated by other types of DSBs.</p>
]]></description>
<dc:creator><![CDATA[Yin, B., Savic, V., Juntilla, M. M., Bredemeyer, A. L., Yang-Iott, K. S., Helmink, B. A., Koretzky, G. A., Sleckman, B. P., Bassing, C. H.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:36 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091320</dc:identifier>
<dc:title><![CDATA[Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2625</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2639</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2625</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2641?rss=1">
<title><![CDATA[TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2641?rss=1</link>
<description><![CDATA[
<p>B lymphocyte&ndash;intrinsic Toll-like receptor (TLR) signals amplify humoral immunity and can exacerbate autoimmune diseases. We identify a new mechanism by which TLR signals may contribute to autoimmunity and chronic inflammation. We show that TLR4 signaling enhances B lymphocyte trafficking into lymph nodes (LNs), induces B lymphocyte clustering and interactions within LN follicles, leads to sustained in vivo B cell proliferation, overcomes the restriction that limits the access of nonantigen-activated B cells to germinal center dark zones, and enhances the generation of memory and plasma cells. Intravital microscopy and in vivo tracking studies of B cells transferred to recipient mice revealed that TLR4-activated, but not nonstimulated, B cells accumulated within the dark zones of preexisting germinal centers even when transferred with antigen-specific B cells. The TLR4-activated cells persist much better than nonstimulated cells, expanding both within the memory and plasma cell compartments. TLR-mediated activation of B cells may help to feed and stabilize the spontaneous and ectopic germinal centers that are so commonly found in autoimmune individuals and that accompany chronic inflammation.</p>
]]></description>
<dc:creator><![CDATA[Hwang, I.-Y., Park, C., Harrison, K., Kehrl, J. H.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:36 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091982</dc:identifier>
<dc:title><![CDATA[TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2641</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2657</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2641</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2659?rss=1">
<title><![CDATA[Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2659?rss=1</link>
<description><![CDATA[
<p>The origin of IgM<sup>+</sup>CD27<sup>+</sup> B lymphocytes with mutated IgV genes, which account for ~20% of human peripheral blood (PB) B cells, is controversially discussed. A generation in a primary diversification pathway, in T cell&ndash;independent immune responses, or in T cell&ndash;dependent germinal center (GC) reactions has been proposed. We show here that IgM<sup>+</sup>IgD<sup>+</sup>CD27<sup>+</sup> and IgM<sup>+</sup>IgD<sup>&ndash;/low</sup>CD27<sup>+</sup> B cell subsets carry, like class-switched memory B cells, mutations in the <I>Bcl6</I> gene as a genetic trait of a GC experience. Moreover, the identification of PB IgM<sup>+</sup>IgD<sup>+</sup>CD27<sup>+</sup> B cells clonally related to GC-derived IgG<sup>+</sup> memory B cells with shared and distinct IgV gene mutations demonstrates the GC origin also of the former subset. These findings provide genetic evidence for a GC derivation of somatically mutated IgM<sup>+</sup> B cells and indicate that adult humans harbor a large population of IgM<sup>+</sup>IgD<sup>+</sup> post-GC memory B cells. Furthermore, the analysis revealed that a highly diverse and often very large population of memory B cells is generated from a given GC B cell clone, and that (preferentially IgM) memory B cells are generated already early in the GC reaction. This provides novel insights into the dynamics of GC reactions and the generation of a memory B cell repertoire.</p>
]]></description>
<dc:creator><![CDATA[Seifert, M., Kuppers, R.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:36 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091087</dc:identifier>
<dc:title><![CDATA[Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2659</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2669</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2659</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2671?rss=1">
<title><![CDATA[Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2671?rss=1</link>
<description><![CDATA[
<p>B cell activation factor of the TNF family (BAFF) activates noncanonical nuclear factor B (NF-B) heterodimers that promote B cell survival. We show that although MALT1 is largely dispensable for canonical NF-B signaling downstream of the B cell receptor, the absence of MALT1 results in impaired BAFF-induced phosphorylation of NF-B2 (p100), p100 degradation, and RelB nuclear translocation in B220<sup>+</sup> B cells. This corresponds with impaired survival of MALT1<sup>&ndash;/&ndash;</sup> marginal zone (MZ) but not follicular B cells in response to BAFF stimulation in vitro. MALT1<sup>&ndash;/&ndash;</sup> MZ B cells also express higher amounts of TRAF3, a known negative regulator of BAFF receptor&ndash;mediated signaling, and TRAF3 was found to interact with MALT1. Furthermore, phenotypes associated with overexpression of BAFF, including increased MZ B cell numbers, elevated serum immunoglobulin titers, and spontaneous germinal center formation, were found to be dependent on B cell&ndash;intrinsic MALT1 expression. Our results demonstrate a novel role for MALT1 in biological outcomes induced by BAFF-mediated signal transduction.</p>
]]></description>
<dc:creator><![CDATA[Tusche, M. W., Ward, L. A., Vu, F., McCarthy, D., Quintela-Fandino, M., Ruland, J., Gommerman, J. L., Mak, T. W.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:36 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091802</dc:identifier>
<dc:title><![CDATA[Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2671</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2683</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2671</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2685?rss=1">
<title><![CDATA[The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2685?rss=1</link>
<description><![CDATA[
<p>The transcription factor Ets1 contributes to the differentiation of CD8 lineage cells in the thymus, but how it does so is not understood. In this study, we demonstrate that Ets1 is required for the proper termination of CD4 expression during the differentiation of major histocompatability class 1 (MHC I)&ndash;restricted thymocytes, but not for other events associated with their positive selection, including the initiation of cytotoxic gene expression, corticomedullary migration, or thymus exit. We further show that Ets1 promotes expression of Runx3, a transcription factor important for CD8 T cell differentiation and the cessation of <I>Cd4</I> gene expression. Enforced Runx3 expression in Ets1-deficient MHC I&ndash;restricted thymocytes largely rescued their impaired <I>Cd4</I> silencing, indicating that Ets1 is not required for Runx3 function. Finally, we document that Ets1 binds at least two evolutionarily conserved regions within the <I>Runx3</I> gene in vivo, supporting the possibility that Ets1 directly contributes to <I>Runx3</I> transcription. These findings identify Ets1 as a key player during CD8 lineage differentiation and indicate that it acts, at least in part, by promoting <I>Runx3</I> expression.</p>
]]></description>
<dc:creator><![CDATA[Zamisch, M., Tian, L., Grenningloh, R., Xiong, Y., Wildt, K. F., Ehlers, M., Ho, I-C., Bosselut, R.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:36 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20092024</dc:identifier>
<dc:title><![CDATA[The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2685</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2699</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2685</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2701?rss=1">
<title><![CDATA[Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2701?rss=1</link>
<description><![CDATA[
<p>Forkhead box P3 (FOXP3)<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup> inducible regulatory T (iT reg) cells play an important role in immune tolerance and homeostasis. In this study, we show that the transforming growth factor-&beta; (TGF-&beta;) induces the expression of the Runt-related transcription factors RUNX1 and RUNX3 in CD4<sup>+</sup> T cells. This induction seems to be a prerequisite for the binding of RUNX1 and RUNX3 to three putative RUNX binding sites in the <I>FOXP3</I> promoter. Inactivation of the gene encoding RUNX cofactor core-binding factor-&beta; (CBF&beta;) in mice and small interfering RNA (siRNA)-mediated suppression of RUNX1 and RUNX3 in human T cells resulted in reduced expression of Foxp3. The in vivo conversion of naive CD4<sup>+</sup> T cells into Foxp3<sup>+</sup> iT reg cells was significantly decreased in adoptively transferred <I>Cbfb<sup>F/F</sup> CD4-cre</I> naive T cells into <I>Rag2<sup>&ndash;/&ndash;</sup></I> mice. Both RUNX1 and RUNX3 siRNA silenced human T reg cells and <I>Cbfb<sup>F/F</sup> CD4-cre</I> mouse T reg cells showed diminished suppressive function in vitro. Circulating human CD4<sup>+</sup> CD25<sup>high</sup> CD127<sup>&ndash;</sup> T reg cells significantly expressed higher levels of RUNX3, FOXP3, and TGF-&beta; mRNA compared with CD4<sup>+</sup>CD25<sup>&ndash;</sup> cells. Furthermore, FOXP3 and RUNX3 were colocalized in human tonsil T reg cells. These data demonstrate Runx transcription factors as a molecular link in TGF-&beta;&ndash;induced Foxp3 expression in iT reg cell differentiation and function.</p>
]]></description>
<dc:creator><![CDATA[Klunker, S., Chong, M. M.W., Mantel, P.-Y., Palomares, O., Bassin, C., Ziegler, M., Ruckert, B., Meiler, F., Akdis, M., Littman, D. R., Akdis, C. A.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:36 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090596</dc:identifier>
<dc:title><![CDATA[Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2701</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2715</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2701</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2717?rss=1">
<title><![CDATA[Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2717?rss=1</link>
<description><![CDATA[
<p>Semen is the main vector for HIV-1 dissemination worldwide. It contains three major sources of infectious virus: free virions, infected leukocytes, and spermatozoa-associated virions. We focused on the interaction of HIV-1 with human spermatozoa and dendritic cells (DCs). We report that heparan sulfate is expressed in spermatozoa and plays an important role in the capture of HIV-1. Spermatozoa-attached virus is efficiently transmitted to DCs, macrophages, and T cells. Interaction of spermatozoa with DCs not only leads to the transmission of HIV-1 and the internalization of the spermatozoa but also results in the phenotypic maturation of DCs and the production of IL-10 but not IL-12p70. At low values of extracellular pH (~6.5 pH units), similar to those found in the vaginal mucosa after sexual intercourse, the binding of HIV-1 to the spermatozoa and the consequent transmission of HIV-1 to DCs were strongly enhanced. Our observations support the notion that far from being a passive carrier, spermatozoa acting in concert with DCs might affect the early course of sexual transmission of HIV-1 infection.</p>
]]></description>
<dc:creator><![CDATA[Ceballos, A., Remes Lenicov, F., Sabatte, J., Rodriguez Rodrigues, C., Cabrini, M., Jancic, C., Raiden, S., Donaldson, M., Agustin Pasqualini, R., Marin-Briggiler, C., Vazquez-Levin, M., Capani, F., Amigorena, S., Geffner, J.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:36 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091579</dc:identifier>
<dc:title><![CDATA[Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2717</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2733</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2717</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2735?rss=1">
<title><![CDATA[Key role of T cell defects in age-related vulnerability to West Nile virus]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2735?rss=1</link>
<description><![CDATA[
<p>West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that becomes increasingly more prevalent over the age of 50 and is 40&ndash;50<FONT FACE="arial,helvetica">x</FONT> more prevalent in people over the age of 70, compared with adults under the age of 40. In a mouse model of age-related vulnerability to WNV, we demonstrate that death correlates with increased viral titers in the brain and that this loss of virus control with age was the result of defects in the CD4 and CD8 T cell response against WNV. Specific age-related defects in T cell responses against dominant WNV epitopes were detected at the level of cytokine and lytic granule production, each of which are essential for resistance against WNV, and in the ability to generate multifunctional anti-WNV effector T cells, which are believed to be critical for robust antiviral immunity. In contrast, at the peak of the response, old and adult T cells exhibited superimposable peptide sensitivity. Most importantly, although the adult CD4 or CD8 T cells readily protected immunodeficient mice upon adoptive transfer, old T cells of either subset were unable to provide WNV-specific protection. Consistent with a profound qualitative and quantitative defect in T cell immunity, old brains contained at least 12<FONT FACE="arial,helvetica">x</FONT> fewer total effector CD8 T cells compared with adult mice at the peak of brain infection. These findings identify potential targets for immunomodulation and treatment to combat lethal WNV infection in the elderly.</p>
]]></description>
<dc:creator><![CDATA[Brien, J. D., Uhrlaub, J. L., Hirsch, A., Wiley, C. A., Nikolich-Zugich, J.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:37 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090222</dc:identifier>
<dc:title><![CDATA[Key role of T cell defects in age-related vulnerability to West Nile virus]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2735</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2745</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2735</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2747?rss=1">
<title><![CDATA[A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2747?rss=1</link>
<description><![CDATA[
<p>Infection by <I>Toxoplasma gondii</I> down-regulates the host innate immune responses, such as proinflammatory cytokine production, in a Stat3-dependent manner. A forward genetic approach recently demonstrated that the type II strain fails to suppress immune responses because of a potential defect in a highly polymorphic parasite-derived kinase, ROP16. We generated ROP16-deficient type I parasites by reverse genetics and found a severe defect in parasite-induced Stat3 activation, culminating in enhanced production of interleukin (IL) 6 and IL-12 p40 in the infected macrophages. Furthermore, overexpression of ROP16 but not ROP18 in mammalian cells resulted in Stat3 phosphorylation and strong activation of Stat3-dependent promoters. In addition, kinase-inactive ROP16 failed to activate Stat3. Comparison of type I and type II ROP16 revealed that a single amino acid substitution in the kinase domain determined the strain difference in terms of Stat3 activation. Moreover, ROP16 bound Stat3 and directly induced phosphorylation of this transcription factor. These results formally establish an essential and direct requirement of ROP16 in parasite-induced Stat3 activation and the significance of a single amino acid replacement in the function of type II ROP16.</p>
]]></description>
<dc:creator><![CDATA[Yamamoto, M., Standley, D. M., Takashima, S., Saiga, H., Okuyama, M., Kayama, H., Kubo, E., Ito, H., Takaura, M., Matsuda, T., Soldati-Favre, D., Takeda, K.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:37 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091703</dc:identifier>
<dc:title><![CDATA[A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2747</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2760</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2747</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2761?rss=1">
<title><![CDATA[The G protein {beta}{gamma} subunit mediates reannealing of adherens junctions to reverse endothelial permeability increase by thrombin]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2761?rss=1</link>
<description><![CDATA[
<p>The inflammatory mediator thrombin proteolytically activates protease-activated receptor (PAR1) eliciting a transient, but reversible increase in vascular permeability. PAR1-induced dissociation of G subunit from heterotrimeric Gq and G12/G13 proteins is known to signal the increase in endothelial permeability. However, the role of released G&beta; is unknown. We now show that impairment of G&beta; function does not affect the permeability increase induced by PAR1, but prevents reannealing of adherens junctions (AJ), thereby persistently elevating endothelial permeability. We observed that in the naive endothelium G&beta;1, the predominant G&beta; isoform is sequestered by receptor for activated C kinase 1 (RACK1). Thrombin induced dissociation of G&beta;1 from RACK1, resulting in G&beta;1 interaction with Fyn and focal adhesion kinase (FAK) required for FAK activation. RACK1 depletion triggered G&beta;1 activation of FAK and endothelial barrier recovery, whereas Fyn knockdown interrupted with G&beta;1-induced barrier recovery indicating RACK1 negatively regulates G&beta;1-Fyn signaling. Activated FAK associated with AJ and stimulated AJ reassembly in a Fyn-dependent manner. Fyn deletion prevented FAK activation and augmented lung vascular permeability increase induced by PAR1 agonist. Rescuing FAK activation in <I>fyn<sup>&ndash;/&ndash;</sup></I> mice attenuated the rise in lung vascular permeability. Our results demonstrate that G&beta;1-mediated Fyn activation integrates FAK with AJ, preventing persistent endothelial barrier leakiness.</p>
]]></description>
<dc:creator><![CDATA[Knezevic, N., Tauseef, M., Thennes, T., Mehta, D.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:37 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090652</dc:identifier>
<dc:title><![CDATA[The G protein {beta}{gamma} subunit mediates reannealing of adherens junctions to reverse endothelial permeability increase by thrombin]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2761</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2777</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2761</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2779?rss=1">
<title><![CDATA[Identity of the elusive IgM Fc receptor (Fc{micro}R) in humans]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2779?rss=1</link>
<description><![CDATA[
<p>Although Fc receptors (FcRs) for switched immunoglobulin (Ig) isotypes have been extensively characterized, FcR for IgM (Fc&micro;R) has defied identification. By retroviral expression and functional cloning, we have identified a complementary DNA (cDNA) encoding a bona fide Fc&micro;R in human B-lineage cDNA libraries. Fc&micro;R is defined as a transmembrane sialoglycoprotein of ~60 kD, which contains an extracellular Ig-like domain homologous to two other IgM-binding receptors (polymeric Ig receptor and Fc/&micro;R) but exhibits an exclusive Fc&micro;-binding specificity. The cytoplasmic tail of Fc&micro;R contains conserved Ser and Tyr residues, but none of the Tyr residues match the immunoreceptor tyrosine-based activation, inhibitory, or switch motifs. Unlike other FcRs, the major cell types expressing Fc&micro;R are adaptive immune cells, including B and T lymphocytes. After antigen-receptor ligation or phorbol myristate acetate stimulation, Fc&micro;R expression was up-regulated on B cells but was down-modulated on T cells, suggesting differential regulation of Fc&micro;R expression during B and T cell activation. Although this receptor was initially designated as Fas apoptotic inhibitory molecule 3, or TOSO, our results indicate that Fc&micro;R per se has no inhibitory activity in Fas-mediated apoptosis and that such inhibition is only achieved when anti-Fas antibody of an IgM but not IgG isotype is used for inducing apoptosis.</p>
]]></description>
<dc:creator><![CDATA[Kubagawa, H., Oka, S., Kubagawa, Y., Torii, I., Takayama, E., Kang, D.-W., Gartland, G. L., Bertoli, L. F., Mori, H., Takatsu, H., Kitamura, T., Ohno, H., Wang, J.-Y.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:37 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091107</dc:identifier>
<dc:title><![CDATA[Identity of the elusive IgM Fc receptor (Fc{micro}R) in humans]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2779</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2793</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2779</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2795?rss=1">
<title><![CDATA[Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2795?rss=1</link>
<description><![CDATA[
<p>Leukocyte migration across endothelial cell borders (paracellular) and through endothelial cells (transcellular) appear to be distinct processes. During paracellular migration, membrane from a parajunctional reticulum of interconnected vesicles, the endothelial lateral border recycling compartment (LBRC), moves to surround the leukocyte in a kinesin-mediated, microtubule-dependent manner. We show that transcellular migration likewise requires targeted trafficking of LBRC membrane. We show that in addition to platelet/endothelial cell adhesion molecule (PECAM; CD31), CD99 and junctional adhesion molecule A (JAM-A), but apparently not vascular endothelial cell&ndash;specific cadherin (cadherin 5, CD144), are components of the LBRC. During transcellular migration, LBRC membrane invests the transmigrating leukocyte. Intracellular adhesion molecule 1 (ICAM-1) on the apical endothelial surface is enriched around adherent leukocytes. Depolymerization of microtubules has no effect on ICAM-1 enrichment but blocks targeted trafficking of LBRC membrane and transcellular migration by &gt;90%. Similar to their effects on paracellular transmigration, antibodies against PECAM or CD99, but not JAM-A, block transcellular migration. We conclude that similar molecular mechanisms promote both para- and transcellular migration.</p>
]]></description>
<dc:creator><![CDATA[Mamdouh, Z., Mikhailov, A., Muller, W. A.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:37 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082745</dc:identifier>
<dc:title><![CDATA[Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2795</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2808</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2795</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2809?rss=1">
<title><![CDATA[The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2809?rss=1</link>
<description><![CDATA[
<p>Growth-restricted fetuses are at risk for a variety of lifelong medical conditions. Preeclampsia, a life-threatening hypertensive disorder of pregnancy, is associated with fetuses who suffer from intrauterine growth restriction (IUGR). Recently, emerging evidence indicates that preeclamptic women harbor AT<SUB>1</SUB> receptor agonistic autoantibodies (AT<SUB>1</SUB>-AAs) that contribute to the disease features. However, the exact role of AT<SUB>1</SUB>-AAs in IUGR and the underlying mechanisms have not been identified. We report that these autoantibodies are present in the cord blood of women with preeclampsia and retain the ability to activate AT<SUB>1</SUB> receptors. Using an autoantibody-induced animal model of preeclampsia, we show that AT<SUB>1</SUB>-AAs cross the mouse placenta, enter fetal circulation, and lead to small fetuses with organ growth retardation. AT<SUB>1</SUB>-AAs also induce apoptosis in the placentas of pregnant mice, human villous explants, and human trophoblast cells. Finally, autoantibody-induced IUGR and placental apoptosis are diminished by either losartan or an autoantibody-neutralizing peptide. Thus, these studies identify AT<SUB>1</SUB>-AA as a novel causative factor of preeclampsia-associated IUGR and offer two possible underlying mechanisms: a direct detrimental effect on fetal development by crossing the placenta and entering fetal circulation, and indirectly through AT<SUB>1</SUB>-AA&ndash;induced placental damage. Our findings highlight AT<SUB>1</SUB>-AAs as important therapeutic targets.</p>
]]></description>
<dc:creator><![CDATA[Irani, R. A., Zhang, Y., Blackwell, S. C., Zhou, C. C., Ramin, S. M., Kellems, R. E., Xia, Y.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:37 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090872</dc:identifier>
<dc:title><![CDATA[The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2809</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2822</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2809</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2823?rss=1">
<title><![CDATA[The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2823?rss=1</link>
<description><![CDATA[
<p>The bloodstream is an important route of dissemination of invading pathogens. Most of the small bloodborne pathogens, like bacteria or viruses, are filtered by the spleen or liver sinusoids and presented to the immune system by dendritic cells (DCs) that probe these filters for the presence of foreign antigen (Ag). However, larger pathogens, like helminths or infectious emboli, that exceed 20 &micro;m are mostly trapped in the vasculature of the lung. To determine if Ag trapped here can be presented to cells of the immune system, we used a model of venous embolism of large particulate Ag (in the form of ovalbumin [OVA]-coated Sepharose beads) in the lung vascular bed. We found that large Ags were presented and cross-presented to CD4 and CD8 T cells in the mediastinal lymph nodes (LNs) but not in the spleen or liver-draining LNs. Dividing T cells returned to the lungs, and a short-lived infiltrate consisting of T cells and DCs formed around trapped Ag. This infiltrate was increased when the Toll-like receptor 4 was stimulated and full DC maturation was induced by CD40 triggering. Under these conditions, OVA-specific cytotoxic T lymphocyte responses, as well as humoral immunity, were induced. The T cell response to embolic Ag was severely reduced in mice depleted of CD11c<sup>hi</sup> cells or Ly6C/G<sup>+</sup> cells but restored upon adoptive transfer of Ly6C<sup>hi</sup> monocytes. We conclude that the lung vascular filter represents a largely unexplored site of immune induction that traps large bloodborne Ags for presentation by monocyte-derived DCs.</p>
]]></description>
<dc:creator><![CDATA[Willart, M. A.M., Jan de Heer, H., Hammad, H., Soullie, T., Deswarte, K., Clausen, B. E., Boon, L., Hoogsteden, H. C., Lambrecht, B. N.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:37 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082401</dc:identifier>
<dc:title><![CDATA[The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2823</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2835</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2823</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/12/2837?rss=1">
<title><![CDATA[Niche recycling through division-independent egress of hematopoietic stem cells]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/12/2837?rss=1</link>
<description><![CDATA[
<p>Hematopoietic stem cells (HSCs) are thought to reside in discrete niches through stable adhesion, yet previous studies have suggested that host HSCs can be replaced by transplanted donor HSCs, even in the absence of cytoreductive conditioning. To explain this apparent paradox, we calculated, through cell surface phenotyping and transplantation of unfractionated blood, that ~1&ndash;5% of the total pool of HSCs enters into the circulation each day. Bromodeoxyuridine (BrdU) feeding experiments demonstrated that HSCs in the peripheral blood incorporate BrdU at the same rate as do HSCs in the bone marrow, suggesting that egress from the bone marrow to the blood can occur without cell division and can leave behind vacant HSC niches. Consistent with this, repetitive daily transplantations of small numbers of HSCs administered as new niches became available over the course of 7 d led to significantly higher levels of engraftment than did large, single-bolus transplantations of the same total number of HSCs. These data provide insight as to how HSC replacement can occur despite the residence of endogenous HSCs in niches, and suggest therapeutic interventions that capitalize upon physiological HSC egress.</p>
]]></description>
<dc:creator><![CDATA[Bhattacharya, D., Czechowicz, A., Ooi, A.G. L., Rossi, D. J., Bryder, D., Weissman, I. L.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 15:26:37 PST</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090778</dc:identifier>
<dc:title><![CDATA[Niche recycling through division-independent egress of hematopoietic stem cells]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/12/2837</prism:object>
<prism:number>12</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2850</prism:endingPage>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:startingPage>2837</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2351?rss=1">
<title><![CDATA[Id2-, ROR{gamma}t-, and LT{beta}R-independent initiation of lymphoid organogenesis in ocular immunity]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2351?rss=1</link>
<description><![CDATA[
<p>The eye is protected by the ocular immunosurveillance system. We show that tear duct&ndash;associated lymphoid tissue (TALT) is located in the mouse lacrimal sac and shares immunological characteristics with mucosa-associated lymphoid tissues (MALTs), including the presence of M cells and immunocompetent cells for antigen uptake and subsequent generation of mucosal immune responses against ocularly encountered antigens and bacteria such as <I>Pseudomonas aeruginosa</I>. Initiation of TALT genesis began postnatally; it occurred even in germ-free conditions and was independent of signaling through organogenesis regulators, including inhibitor of DNA binding/differentiation 2, retinoic acid&ndash;related orphan receptor t, lymphotoxin (LT) 1&beta;2&ndash;LT&beta;R, and lymphoid chemokines (CCL19, CCL21, and CXCL13). Thus, TALT shares immunological features with MALT but has a distinct tissue genesis mechanism and plays a key role in ocular immunity.</p>
]]></description>
<dc:creator><![CDATA[Nagatake, T., Fukuyama, S., Kim, D.-Y., Goda, K., Igarashi, O., Sato, S., Nochi, T., Sagara, H., Yokota, Y., Jetten, A. M., Kaisho, T., Akira, S., Mimuro, H., Sasakawa, C., Fukui, Y., Fujihashi, K., Akiyama, T., Inoue, J.-i., Penninger, J. M., Kunisawa, J., Kiyono, H.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091436</dc:identifier>
<dc:title><![CDATA[Id2-, ROR{gamma}t-, and LT{beta}R-independent initiation of lymphoid organogenesis in ocular immunity]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2351</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2364</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2351</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2365?rss=1">
<title><![CDATA[Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2365?rss=1</link>
<description><![CDATA[
<p>Platelet activation at a site of vascular injury is essential for the arrest of bleeding; however, excessive platelet activation at a site of arterial damage can result in the unwarranted formation of arterial thrombi, precipitating acute myocardial infarction, or ischemic stroke. Activation of platelets beyond the purpose of hemostasis may occur when substances facilitating thrombus growth and stability accumulate. Human platelets contain matrix metalloproteinase 2 (MMP-2) and release it upon activation. Active MMP-2 amplifies the platelet aggregation response to several agonists by potentiating phosphatidylinositol 3-kinase activation. Using several in vivo thrombosis models, we show that the inactivation of the MMP-2 gene prevented thrombosis induced by weak, but not strong, stimuli in mice but produced only a moderate prolongation of the bleeding time. Moreover, using cross-transfusion experiments and <I>wild-type/MMP-2<sup>&ndash;/&ndash;</sup></I> chimeric mice, we show that it is platelet-derived MMP-2 that facilitates thrombus formation. Finally, we show that platelets activated by a mild vascular damage induce thrombus formation at a downstream arterial injury site by releasing MMP-2. Thus, platelet-derived MMP-2 plays a crucial role in thrombus formation by amplifying the response of platelets to weak activating stimuli. These findings open new possibilities for the prevention of thrombosis by the development of MMP-2 inhibitors.</p>
]]></description>
<dc:creator><![CDATA[Momi, S., Falcinelli, E., Giannini, S., Ruggeri, L., Cecchetti, L., Corazzi, T., Libert, C., Gresele, P.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090687</dc:identifier>
<dc:title><![CDATA[Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2365</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2379</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2365</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2381?rss=1">
<title><![CDATA[Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2381?rss=1</link>
<description><![CDATA[
<p>Blood coagulation starts immediately after damage to the vascular endothelium. This system is essential for minimizing blood loss from an injured blood vessel but also contributes to vascular thrombosis. Although it has long been thought that the intrinsic coagulation pathway is not important for clotting in vivo, recent data obtained with genetically altered mice indicate that contact phase proteins seem to be essential for thrombus formation. We show that recombinant <I>Ixodes ricinus</I> contact phase inhibitor (Ir-CPI), a Kunitz-type protein expressed by the salivary glands of the tick <I>Ixodes ricinus</I>, specifically interacts with activated human contact phase factors (FXIIa, FXIa, and kallikrein) and prolongs the activated partial thromboplastin time (aPTT) in vitro. The effects of Ir-CPI were also examined in vivo using both venous and arterial thrombosis models. Intravenous administration of Ir-CPI in rats and mice caused a dose-dependent reduction in venous thrombus formation and revealed a defect in the formation of arterial occlusive thrombi. Moreover, mice injected with Ir-CPI are protected against collagen- and epinephrine-induced thromboembolism. Remarkably, the effective antithrombotic dose of Ir-CPI did not promote bleeding or impair blood coagulation parameters. To conclude, our results show that a contact phase inhibitor is an effective and safe antithrombotic agent in vivo.</p>
]]></description>
<dc:creator><![CDATA[Decrem, Y., Rath, G., Blasioli, V., Cauchie, P., Robert, S., Beaufays, J., Frere, J.-M., Feron, O., Dogne, J.-M., Dessy, C., Vanhamme, L., Godfroid, E.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091007</dc:identifier>
<dc:title><![CDATA[Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2381</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2395</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2381</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2397?rss=1">
<title><![CDATA[Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2397?rss=1</link>
<description><![CDATA[
<p>Activation of vascular smooth muscle cells (VSMCs) to migrate and proliferate is essential for the formation of intimal hyperplasia. Hence, selectively targeting activated VSMCs is a potential strategy against vaso-occlusive disorders such as in-stent restenosis, vein-graft stenosis, and transplant vasculopathy. We show that CD98 heavy chain (CD98hc) is markedly up-regulated in neointimal and cultured VSMCs, and that activated but not quiescent VSMCs require CD98hc for survival. CD98hc mediates integrin signaling and localizes amino acid transporters to the plasma membrane. SMC-specific deletion of CD98hc did not affect normal vessel morphology, indicating that CD98hc was not required for the maintenance of resident quiescent VSMCs; however, CD98hc deletion reduced intimal hyperplasia after arterial injury. Ex vivo and in vitro, loss of CD98hc suppressed proliferation and induced apoptosis in VSMCs. Furthermore, reconstitution with CD98hc mutants showed that CD98hc interaction with integrins was necessary for the survival of VSMCs. These studies establish the importance of CD98hc in VSMC proliferation and survival. Furthermore, loss of CD98hc was selectively deleterious to activated VSMCs while sparing resident quiescent VSMCs, suggesting that activated VSMCs are physiologically dependent on CD98hc, and hence, CD98hc is a potential therapeutic target in vaso-occlusive disorders.</p>
]]></description>
<dc:creator><![CDATA[Fogelstrand, P., Feral, C. C., Zargham, R., Ginsberg, M. H.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082845</dc:identifier>
<dc:title><![CDATA[Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2397</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2406</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2397</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2407?rss=1">
<title><![CDATA[Transforming growth factor {beta} is dispensable for the molecular orchestration of Th17 cell differentiation]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2407?rss=1</link>
<description><![CDATA[
<p>Interleukin (IL)-17&ndash;producing T helper (Th17) cells play a critical role in the pathophysiology of several autoimmune disorders. The differentiation of Th17 cells requires the simultaneous presence of an unusual combination of cytokines: IL-6, a proinflammatory cytokine, and transforming growth factor (TGF) &beta;, an antiinflammatory cytokine. However, the molecular mechanisms by which TGF-&beta; exerts its effects on Th17 cell differentiation remain elusive. We report that TGF-&beta; does not directly promote Th17 cell differentiation but instead acts indirectly by blocking expression of the transcription factors signal transducer and activator of transcription (STAT) 4 and GATA-3, thus preventing Th1 and Th2 cell differentiation. In contrast, TGF-&beta; had no effect on the expression of retinoic acid receptor&ndash;related orphan nuclear receptor t, a Th17-specific transcription factor. Interestingly, in Stat-6<sup>&ndash;/&ndash;</sup>T-bet<sup>&ndash;/&ndash;</sup> mice, which are unable to generate Th1 and Th2 cells, IL-6 alone was sufficient to induce robust differentiation of Th17 cells, whereas TGF-&beta; had no effect, suggesting that TGF-&beta; is dispensable for Th17 cell development. Consequently, BALB/c Stat-6<sup>&ndash;/&ndash;</sup>T-bet<sup>&ndash;/&ndash;</sup> mice, but not wild-type BALB/c mice, were highly susceptible to the development of experimental autoimmune encephalomyelitis, which could be blocked by anti&ndash;IL-17 antibodies but not by anti&ndash;TGF-&beta; antibodies. Collectively, these data provide evidence that TGF-&beta; is not directly required for the molecular orchestration of Th17 cell differentiation.</p>
]]></description>
<dc:creator><![CDATA[Das, J., Ren, G., Zhang, L., Roberts, A. I., Zhao, X., Bothwell, A. L.M., Van Kaer, L., Shi, Y., Das, G.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082286</dc:identifier>
<dc:title><![CDATA[Transforming growth factor {beta} is dispensable for the molecular orchestration of Th17 cell differentiation]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2407</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2416</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2407</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2417?rss=1">
<title><![CDATA[Staphylococcus aureus synthesizes adenosine to escape host immune responses]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2417?rss=1</link>
<description><![CDATA[
<p><I>Staphylococcus aureus</I> infects hospitalized or healthy individuals and represents the most frequent cause of bacteremia, treatment of which is complicated by the emergence of methicillin-resistant <I>S. aureus</I>. We examined the ability of <I>S. aureus</I> to escape phagocytic clearance in blood and identified adenosine synthase A (AdsA), a cell wall&ndash;anchored enzyme that converts adenosine monophosphate to adenosine, as a critical virulence factor. Staphylococcal synthesis of adenosine in blood, escape from phagocytic clearance, and subsequent formation of organ abscesses were all dependent on <I>adsA</I> and could be rescued by an exogenous supply of adenosine. An AdsA homologue was identified in the anthrax pathogen, and adenosine synthesis also enabled escape of <I>Bacillus anthracis</I> from phagocytic clearance. Collectively, these results suggest that staphylococci and other bacterial pathogens exploit the immunomodulatory attributes of adenosine to escape host immune responses.</p>
]]></description>
<dc:creator><![CDATA[Thammavongsa, V., Kern, J. W., Missiakas, D. M., Schneewind, O.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090097</dc:identifier>
<dc:title><![CDATA[Staphylococcus aureus synthesizes adenosine to escape host immune responses]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2417</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2427</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2417</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2429?rss=1">
<title><![CDATA[Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2429?rss=1</link>
<description><![CDATA[
<p>Shiga-toxigenic <I>Escherichia coli</I> (STEC) use subtilase cytotoxin (SubAB) to interfere with adaptive immunity. Its inhibition of immunoglobulin secretion is both rapid and profound. SubAB favors cleavage of the newly synthesized immunoglobulin heavy chain&ndash;binding protein (BiP) to yield a C-terminal fragment that contains BiP&rsquo;s substrate-binding domain. In the absence of its regulatory nucleotide-binding domain, the SubAB-cleaved C-terminal BiP fragment remains tightly bound to newly synthesized immunoglobulin light chains, resulting in retention of light chains in the endoplasmic reticulum (ER). Immunoglobulins are thus detained in the ER, making impossible the secretion of antibodies by SubAB-treated B cells. The inhibitory effect of SubAB is highly specific for antibody secretion, because other secretory proteins such as IL-6 are released normally from SubAB-treated B cells. Although SubAB also causes BiP cleavage in HepG2 hepatoma cells, (glyco)protein secretion continues unabated in SubAB-exposed HepG2 cells. This specific block in antibody secretion is a novel means of immune evasion for STEC. The differential cleavage of newly synthesized versus "aged" BiP by SubAB in the ER provides insight into the architecture of the ER compartments involved.</p>
]]></description>
<dc:creator><![CDATA[Hu, C.-C. A., Dougan, S. K., Winter, S. V., Paton, A. W., Paton, J. C., Ploegh, H. L.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090782</dc:identifier>
<dc:title><![CDATA[Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2429</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2440</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2429</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2441?rss=1">
<title><![CDATA[Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2441?rss=1</link>
<description><![CDATA[
<p>In normal T cell progenitors, phosphoinositide-dependent kinase l (PDK1)&ndash;mediated phosphorylation and activation of protein kinase B (PKB) is essential for the phosphorylation and inactivation of Foxo family transcription factors, and also controls T cell growth and proliferation. The current study has characterized the role of PDK1 in the pathology caused by deletion of the tumor suppressor phosphatase and tensin homologue deleted on chromosome 10 (PTEN). PDK1 is shown to be essential for lymphomagenesis caused by deletion of PTEN in T cell progenitors. However, PTEN deletion bypasses the normal PDK1-controlled signaling pathways that determine thymocyte growth and proliferation. PDK1 does have important functions in PTEN-null thymocytes, notably to control the PKB&ndash;Foxo signaling axis and to direct the repertoire of adhesion and chemokine receptors expressed by PTEN-null T cells. The results thus provide two novel insights concerning pathological signaling caused by PTEN loss in lymphocytes. First, PTEN deletion bypasses the normal PDK1-controlled metabolic checkpoints that determine cell growth and proliferation. Second, PDK1 determines the cohort of chemokine and adhesion receptors expressed by PTEN-null cells, thereby controlling their migratory capacity.</p>
]]></description>
<dc:creator><![CDATA[Finlay, D. K., Sinclair, L. V., Feijoo, C., Waugh, C. M., Hagenbeek, T. J., Spits, H., Cantrell, D. A.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090219</dc:identifier>
<dc:title><![CDATA[Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2441</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2454</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2441</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2455?rss=1">
<title><![CDATA[Mast cell-derived particles deliver peripheral signals to remote lymph nodes]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2455?rss=1</link>
<description><![CDATA[
<p>During infection, signals from the periphery are known to reach draining lymph nodes (DLNs), but how these molecules, such as inflammatory cytokines, traverse the significant distances involved without dilution or degradation remains unclear. We show that peripheral mast cells, upon activation, release stable submicrometer heparin-based particles containing tumor necrosis factor and other proteins. These complexes enter lymphatic vessels and rapidly traffic to the DLNs. This physiological drug delivery system facilitates communication between peripheral sites of inflammation and remote secondary lymphoid tissues.</p>
]]></description>
<dc:creator><![CDATA[Kunder, C. A., St. John, A. L., Li, G., Leong, K. W., Berwin, B., Staats, H. F., Abraham, S. N.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090805</dc:identifier>
<dc:title><![CDATA[Mast cell-derived particles deliver peripheral signals to remote lymph nodes]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2455</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2467</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2455</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2469?rss=1">
<title><![CDATA[T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2469?rss=1</link>
<description><![CDATA[
<p>During a screen for ethylnitrosourea-induced mutations in mice affecting blood natural killer (NK) cells, we identified a strain, designated Duane, in which NK cells were reduced in blood and spleen but increased in lymph nodes (LNs) and bone marrow (BM). The accumulation of NK cells in LNs reflected a decreased ability to exit into lymph. This strain carries a point mutation within <I>Tbx21</I> (T-bet), which generates a defective protein. Duane NK cells have a 30-fold deficiency in sphingosine-1-phosphate receptor 5 (S1P<SUB>5</SUB>) transcript levels, and S1P<SUB>5</SUB>-deficient mice exhibit an egress defect similar to Duane. Chromatin immunoprecipitation confirms binding of T-bet to the <I>S1pr5</I> locus. S1P-deficient mice exhibit a more severe NK cell egress block, and the FTY720-sensitive S1P<SUB>1</SUB> also plays a role in NK cell egress from LNs. S1P<SUB>5</SUB> is not inhibited by CD69, a property that may facilitate trafficking of activated NK cells to effector sites. Finally, the accumulation of NK cells within BM of S1P-deficient mice was associated with reduced numbers in BM sinusoids, suggesting a role for S1P in BM egress. In summary, these findings identify S1P<SUB>5</SUB> as a T-bet&ndash;induced gene that is required for NK cell egress from LNs and BM.</p>
]]></description>
<dc:creator><![CDATA[Jenne, C. N., Enders, A., Rivera, R., Watson, S. R., Bankovich, A. J., Pereira, J. P., Xu, Y., Roots, C. M., Beilke, J. N., Banerjee, A., Reiner, S. L., Miller, S. A., Weinmann, A. S., Goodnow, C. C., Lanier, L. L., Cyster, J. G., Chun, J.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090525</dc:identifier>
<dc:title><![CDATA[T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2469</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2481</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2469</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2483?rss=1">
<title><![CDATA[Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2483?rss=1</link>
<description><![CDATA[
<p>Mesenchymal stem cells (MSCs) are defined as cells that undergo sustained in vitro growth and can give rise to multiple mesenchymal lineages. Because MSCs have only been isolated from tissue in culture, the equivalent cells have not been identified in vivo and little is known about their physiological roles or even their exact tissue location. In this study, we used phenotypic, morphological, and functional criteria to identify and prospectively isolate a subset of MSCs (PDGFR<sup>+</sup>Sca-1<sup>+</sup>CD45<sup>&ndash;</sup>TER119<sup>&ndash;</sup>) from adult mouse bone marrow. Individual MSCs generated colonies at a high frequency and could differentiate into hematopoietic niche cells, osteoblasts, and adipocytes after in vivo transplantation. Naive MSCs resided in the perivascular region in a quiescent state. This study provides the useful method needed to identify MSCs as defined in vivo entities.</p>
]]></description>
<dc:creator><![CDATA[Morikawa, S., Mabuchi, Y., Kubota, Y., Nagai, Y., Niibe, K., Hiratsu, E., Suzuki, S., Miyauchi-Hara, C., Nagoshi, N., Sunabori, T., Shimmura, S., Miyawaki, A., Nakagawa, T., Suda, T., Okano, H., Matsuzaki, Y.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091046</dc:identifier>
<dc:title><![CDATA[Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2483</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2496</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2483</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2497?rss=1">
<title><![CDATA[CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2497?rss=1</link>
<description><![CDATA[
<p>Group 1 CD1 (CD1a, CD1b, and CD1c)&ndash;restricted T cells recognize mycobacterial lipid antigens and are found at higher frequencies in <I>Mycobacterium tuberculosis</I> (Mtb)&ndash;infected individuals. However, their role and dynamics during infection remain unknown because of the lack of a suitable small animal model. We have generated human group 1 CD1 transgenic (hCD1Tg) mice that express all three human group 1 CD1 isoforms and support the development of group 1 CD1&ndash;restricted T cells with diverse T cell receptor usage. Both mycobacterial infection and immunization with Mtb lipids elicit group 1 CD1&ndash;restricted Mtb lipid&ndash;specific T cell responses in hCD1Tg mice. In contrast to CD1d-restricted NKT cells, which rapidly respond to initial stimulation but exhibit anergy upon reexposure, group 1 CD1&ndash;restricted T cells exhibit delayed primary responses and more rapid secondary responses, similar to conventional T cells. Collectively, our data demonstrate that group 1 CD1&ndash;restricted T cells participate in adaptive immune responses upon mycobacterial infection and could serve as targets for the development of novel Mtb vaccines.</p>
]]></description>
<dc:creator><![CDATA[Felio, K., Nguyen, H., Dascher, C. C., Choi, H.-J., Li, S., Zimmer, M. I., Colmone, A., Moody, D. B., Brenner, M. B., Wang, C.-R.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:00 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090898</dc:identifier>
<dc:title><![CDATA[CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2497</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2509</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2497</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2511?rss=1">
<title><![CDATA[Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2511?rss=1</link>
<description><![CDATA[
<p>Type I diabetes mellitus is caused by autoimmune destruction of pancreatic &beta; cells, and effective treatment of the disease might require rescuing &beta; cell function in a context of reinstalled immune tolerance. Sertoli cells (SCs) are found in the testes, where their main task is to provide local immunological protection and nourishment to developing germ cells. SCs engraft, self-protect, and coprotect allogeneic and xenogeneic grafts from immune destruction in different experimental settings. SCs have also been successfully implanted into the central nervous system to create a regulatory environment to the surrounding tissue which is trophic and counter-inflammatory. We report that isolated neonatal porcine SC, administered alone in highly biocompatible microcapsules, led to diabetes prevention and reversion in the respective 88 and 81% of overtly diabetic (nonobese diabetic [NOD]) mice, with no need for additional &beta; cell or insulin therapy. The effect was associated with restoration of systemic immune tolerance and detection of functional pancreatic islets that consisted of glucose-responsive and insulin-secreting cells. Curative effects by SC were strictly dependent on efficient tryptophan metabolism in the xenografts, leading to TGF-&beta;&ndash;dependent emergence of autoantigen-specific regulatory T cells and recovery of &beta; cell function in the diabetic recipients.</p>
]]></description>
<dc:creator><![CDATA[Fallarino, F., Luca, G., Calvitti, M., Mancuso, F., Nastruzzi, C., Fioretti, M. C., Grohmann, U., Becchetti, E., Burgevin, A., Kratzer, R., van Endert, P., Boon, L., Puccetti, P., Calafiore, R.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:01 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090134</dc:identifier>
<dc:title><![CDATA[Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2511</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2526</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2511</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2527?rss=1">
<title><![CDATA[A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2527?rss=1</link>
<description><![CDATA[
<p>ZAP-70 is critical for T cell receptor (TCR) signaling. Tyrosine to phenylalanine mutations of Y315 and Y319 in ZAP-70 suggest these residues function to recruit downstream effector molecules, but mutagenesis and crystallization studies reveal that these residues also play an important role in autoinhibition ZAP-70. To address the importance of the scaffolding function, we generated a <I>zap70</I> mutant mouse (YYAA mouse) with Y315 and Y319 both mutated to alanines. These YYAA mice reveal that the scaffolding function is important for normal development and function. Moreover, the YYAA mice have many similarities to a previously identified ZAP-70 mutant mouse, SKG, which harbors a distinct hypomorphic mutation. Both YYAA and SKG mice have impaired T cell development and hyporesponsiveness to TCR stimulation, markedly reduced numbers of thymic T regulatory cells and defective positive and negative selection. YYAA mice, like SKG mice, develop rheumatoid factor antibodies, but fail to develop autoimmune arthritis. Signaling differences that result from ZAP-70 mutations appear to skew the TCR repertoire in ways that differentially influence propensity to autoimmunity versus autoimmune disease susceptibility. By uncoupling the relative contribution from T regulatory cells and TCR repertoire during thymic selection, our data help to identify events that may be important, but alone are insufficient, for the development of autoimmune disease.</p>
]]></description>
<dc:creator><![CDATA[Hsu, L.-Y., Tan, Y. X., Xiao, Z., Malissen, M., Weiss, A.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:01 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082902</dc:identifier>
<dc:title><![CDATA[A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2527</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2541</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2527</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2543?rss=1">
<title><![CDATA[Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2543?rss=1</link>
<description><![CDATA[
<p>Of the potent lipid inflammatory mediators comprising the cysteinyl leukotrienes (LTs; LTC<SUB>4</SUB>, LTD<SUB>4</SUB>, and LTE<SUB>4</SUB>), only LTE<SUB>4</SUB> is stable and abundant in vivo. Although LTE<SUB>4</SUB> shows negligible activity at the type 1 and 2 receptors for cys-LTs (CysLT<SUB>1</SUB>R and CysLT<SUB>2</SUB>R), it is a powerful inducer of mucosal eosinophilia and airway hyperresponsiveness in humans with asthma. We show that the adenosine diphosphate (ADP)&ndash;reactive purinergic (P2Y<SUB>12</SUB>) receptor is required for LTE<SUB>4</SUB>-mediated pulmonary inflammation. P2Y<SUB>12</SUB> receptor expression permits LTE<SUB>4</SUB> -induced activation of extracellular signal-regulated kinase in Chinese hamster ovary cells and permits chemokine and prostaglandin D<SUB>2</SUB> production by LAD2 cells, a human mast cell line. P2Y<SUB>12</SUB> receptor expression by LAD2 cells is required for competition between radiolabeled ADP and unlabeled LTE<SUB>4</SUB> but not for direct binding of LTE<SUB>4</SUB>, suggesting that P2Y<SUB>12</SUB> complexes with another receptor to recognize LTE<SUB>4</SUB>. Administration of LTE<SUB>4</SUB> to the airways of sensitized mice potentiates eosinophilia, goblet cell metaplasia, and expression of interleukin-13 in response to low-dose aerosolized allergen. These responses persist in mice lacking both CysLT<SUB>1</SUB>R and CysLT<SUB>2</SUB>R but not in mice lacking P2Y<SUB>12</SUB> receptors. The effects of LTE<SUB>4</SUB> on P2Y<SUB>12</SUB> in the airway were abrogated by platelet depletion. Thus, the P2Y<SUB>12</SUB> receptor is required for proinflammatory actions of the stable abundant mediator LTE<SUB>4</SUB> and is a novel potential therapeutic target for asthma.</p>
]]></description>
<dc:creator><![CDATA[Paruchuri, S., Tashimo, H., Feng, C., Maekawa, A., Xing, W., Jiang, Y., Kanaoka, Y., Conley, P., Boyce, J. A.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:01 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091240</dc:identifier>
<dc:title><![CDATA[Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2543</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2555</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2543</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/11/2557?rss=1">
<title><![CDATA[KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/11/2557?rss=1</link>
<description><![CDATA[
<p>Human killer cell immunoglobulin-like receptors (KIRs) are distinguished by expansion of activating KIR2DS, whose ligands and functions remain poorly understood. The oldest, most prevalent KIR2DS is KIR2DS4, which is represented by a variable balance between "full-length" and "deleted" forms. We find that full-length 2DS4 is a human histocompatibility leukocyte antigen (HLA) class I receptor that binds specifically to subsets of C1<sup>+</sup> and C2<sup>+</sup> HLA-C and to HLA-A*11, whereas deleted 2DS4 is nonfunctional. Activation of 2DS4<sup>+</sup> NKL cells was achieved with A*1102 as ligand, which differs from A*1101 by unique substitution of lysine 19 for glutamate, but not with A*1101 or HLA-C. Distinguishing KIR2DS4 from other KIR2DS is the proline&ndash;valine motif at positions 71&ndash;72, which is shared with KIR3DL2 and was introduced by gene conversion before separation of the human and chimpanzee lineages. Site-directed swap mutagenesis shows that these two residues are largely responsible for the unique HLA class I specificity of KIR2DS4. Determination of the crystallographic structure of KIR2DS4 shows two major differences from KIR2DL: displacement of contact loop L2 and altered bonding potential because of the substitutions at positions 71 and 72. Correlation between the worldwide distributions of functional KIR2DS4 and HLA-A*11 points to the physiological importance of their mutual interaction.</p>
]]></description>
<dc:creator><![CDATA[Graef, T., Moesta, A. K., Norman, P. J., Abi-Rached, L., Vago, L., Older Aguilar, A. M., Gleimer, M., Hammond, J. A., Guethlein, L. A., Bushnell, D. A., Robinson, P. J., Parham, P.]]></dc:creator>
<dc:date>Mon, 26 Oct 2009 09:19:01 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091010</dc:identifier>
<dc:title><![CDATA[KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/11/2557</prism:object>
<prism:number>11</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2572</prism:endingPage>
<prism:publicationDate>2009-10-26</prism:publicationDate>
<prism:startingPage>2557</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2161?rss=1">
<title><![CDATA[Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2161?rss=1</link>
<description><![CDATA[
<p>Expression of enzymatically inactive caspase-8, or deletion of <I>caspase-8</I> from basal epidermal keratinocytes, triggers chronic skin inflammation in mice. Unlike similar inflammation resulting from arrest of nuclear factor B activation in the epidermal cells, the effect induced by caspase-8 deficiency did not depend on TNF, IL-1, dermal macrophage function, or expression of the toll-like receptor adapter proteins MyD88 or TRIF. Both interferon regulatory factor (IRF) 3 and TANK-binding kinase were constitutively phosphorylated in the caspase-8&ndash;deficient epidermis, and knockdown of IRF3 in the epidermis-derived cells from these mice abolished the expression of up-regulated genes. Temporal and spatial analyses of the alterations in gene expression that result from caspase-8 deficiency reveal that the changes are initiated before birth, around the time that cornification develops, and occur mainly in the suprabasal layer. Finally, we found that caspase-8&ndash;deficient keratinocytes display an enhanced response to gene activation by transfected DNA. Our findings suggest that an enhanced response to endogenous activators of IRF3 in the epidermis, presumably generated in association with keratinocyte differentiation, contributes to the skin inflammatory process triggered by caspase-8 deficiency.</p>
]]></description>
<dc:creator><![CDATA[Kovalenko, A., Kim, J.-C., Kang, T.-B., Rajput, A., Bogdanov, K., Dittrich-Breiholz, O., Kracht, M., Brenner, O., Wallach, D.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090616</dc:identifier>
<dc:title><![CDATA[Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2161</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2177</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2161</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2179?rss=1">
<title><![CDATA[Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2179?rss=1</link>
<description><![CDATA[
<p>Abnormal expression of CEACAM6 is observed at the apical surface of the ileal epithelium in Crohn's disease (CD) patients, and CD ileal lesions are colonized by pathogenic adherent-invasive <I>Escherichia coli</I> (AIEC). We investigated the ability of AIEC reference strain LF82 to colonize the intestinal mucosa and to induce inflammation in CEABAC10 transgenic mice expressing human CEACAMs. AIEC LF82 virulent bacteria, but not nonpathogenic <I>E. coli</I> K-12, were able to persist in the gut of CEABAC10 transgenic mice and to induce severe colitis with reduced survival rate, marked weight loss, increased rectal bleeding, presence of erosive lesions, mucosal inflammation, and increased proinflammatory cytokine expression. The colitis depended on type 1 pili expression by AIEC bacteria and on intestinal CEACAM expression because no sign of colitis was observed in transgenic mice infected with type 1 pili&ndash;negative LF82-<I>fimH</I> isogenic mutant or in wild-type mice infected with AIEC LF82 bacteria. These findings strongly support the hypothesis that in CD patients having an abnormal intestinal expression of CEACAM6, AIEC bacteria via type 1 pili expression can colonize the intestinal mucosa and induce gut inflammation. Thus, targeting AIEC adhesion to gut mucosa represents a new strategy for clinicians to prevent and/or to treat ileal CD.</p>
]]></description>
<dc:creator><![CDATA[Carvalho, F. A., Barnich, N., Sivignon, A., Darcha, C., Chan, C. H.F., Stanners, C. P., Darfeuille-Michaud, A.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090741</dc:identifier>
<dc:title><![CDATA[Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2179</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2189</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2179</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2191?rss=1">
<title><![CDATA[Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2191?rss=1</link>
<description><![CDATA[
<p>Polymorphisms in the interleukin-4 receptor  chain (IL-4R) have been linked to asthma incidence and severity, but a causal relationship has remained uncertain. In particular, a glutamine to arginine substitution at position 576 (Q576R) of IL-4R has been associated with severe asthma, especially in African Americans. We show that mice carrying the Q576R polymorphism exhibited intense allergen-induced airway inflammation and remodeling. The Q576R polymorphism did not affect proximal signal transducer and activator of transcription (STAT) 6 activation, but synergized with STAT6 in a gene target&ndash; and tissue-specific manner to mediate heightened expression of a subset of IL-4&ndash; and IL-13&ndash;responsive genes involved in allergic inflammation. Our findings indicate that the Q576R polymorphism directly promotes asthma in carrier populations by selectively augmenting IL-4R&ndash;dependent signaling.</p>
]]></description>
<dc:creator><![CDATA[Tachdjian, R., Mathias, C., Al Khatib, S., Bryce, P. J., Kim, H. S., Blaeser, F., O'Connor, B. D., Rzymkiewicz, D., Chen, A., Holtzman, M. J., Hershey, G. K., Garn, H., Harb, H., Renz, H., Oettgen, H. C., Chatila, T. A.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091480</dc:identifier>
<dc:title><![CDATA[Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2191</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2204</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2191</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2205?rss=1">
<title><![CDATA[A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2205?rss=1</link>
<description><![CDATA[
<p>The C-type lectin dendritic cell&ndash;specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN) mediates the innate immune recognition of microbial carbohydrates. We investigated the function of this molecule in the host response to pathogens in vivo, by generating mouse lines lacking the DC-SIGN homologues SIGNR1, SIGNR3, and SIGNR5. Resistance to <I>Mycobacterium tuberculosis</I> was impaired only in SIGNR3-deficient animals. SIGNR3 was expressed in lung phagocytes during infection, and interacted with <I>M. tuberculosis</I> bacilli and mycobacterial surface glycoconjugates to induce secretion of critical host defense inflammatory cytokines, including tumor necrosis factor (TNF). SIGNR3 signaling was dependent on an intracellular tyrosine-based motif and the tyrosine kinase Syk. Thus, the mouse DC-SIGN homologue SIGNR3 makes a unique contribution to protection of the host against a pulmonary bacterial pathogen.</p>
]]></description>
<dc:creator><![CDATA[Tanne, A., Ma, B., Boudou, F., Tailleux, L., Botella, H., Badell, E., Levillain, F., Taylor, M. E., Drickamer, K., Nigou, J., Dobos, K. M., Puzo, G., Vestweber, D., Wild, M. K., Marcinko, M., Sobieszczuk, P., Stewart, L., Lebus, D., Gicquel, B., Neyrolles, O.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090188</dc:identifier>
<dc:title><![CDATA[A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2205</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2220</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2205</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2221?rss=1">
<title><![CDATA[The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2221?rss=1</link>
<description><![CDATA[
<p>The role of the angiopoietin-1 (Ang1)&ndash;Tie2 pathway in the pathogenesis of pulmonary arterial hypertension (PAH) is controversial. Although Ang1 is well known to prevent endothelial activation and injury in systemic vascular beds, this pathway has been suggested to mediate pulmonary vascular remodeling in PAH. Therefore, we used transgenic models to determine the effect of increased or decreased Tie2 activity on the development of PAH. We now report modest spontaneous elevation in right ventricular systolic pressure in <I>Tie2</I>-deficient mice (<I>Tie2<sup>+/&ndash;</sup></I>) compared with wild-type (WT) littermate controls, which was exacerbated upon chronic exposure to the clinically relevant PAH triggers, serotonin (5-HT) or interleukin-6 (IL-6). Moreover, overexpression of Ang1 in transgenic mice had no deleterious effect on pulmonary hemodynamics and, if anything, blunted the response to 5-HT. Exposure to 5-HT or IL-6 also decreased lung Ang1 expression, further reducing Tie2 activity and inducing pulmonary apoptosis in the <I>Tie2<sup>+/&ndash;</sup></I> group only. Similarly, cultured pulmonary artery endothelial cells subjected to <I>Tie2</I> silencing demonstrated increased susceptibility to apoptosis after 5-HT treatment. Finally, treatment of <I>Tie2</I>-deficient mice with Z-VAD, a pan-caspase inhibitor, prevented the pulmonary hypertensive response to 5-HT. Thus, these findings firmly establish that endothelial survival signaling via the Ang1&ndash;Tie2 pathway is protective in PAH.</p>
]]></description>
<dc:creator><![CDATA[Kugathasan, L., Ray, J. B., Deng, Y., Rezaei, E., Dumont, D. J., Stewart, D. J.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090389</dc:identifier>
<dc:title><![CDATA[The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2221</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2234</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2221</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2235?rss=1">
<title><![CDATA[Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2235?rss=1</link>
<description><![CDATA[
<p>Natural killer (NK) cells have the potential to deliver both direct antimicrobial effects and regulate adaptive immune responses, but NK cell yields have been reported to vary greatly during different viral infections. Activating receptors, including the Ly49H molecule recognizing mouse cytomegalovirus (MCMV), can stimulate NK cell expansion. To define Ly49H's role in supporting NK cell proliferation and maintenance under conditions of uncontrolled viral infection, experiments were performed in <I>Ly49h<sup>&ndash;/&ndash;</sup></I>, perforin 1 <I>(Prf1)<sup>&ndash;/&ndash;</sup></I>, and wild-type (<I>wt</I>) B6 mice. NK cell numbers were similar in uninfected mice, but relative to responses in MCMV-infected <I>wt</I> mice, NK cell yields declined in the absence of <I>Ly49h</I> and increased in the absence of <I>Prf1</I>, with high rates of proliferation and Ly49H expression on nearly all cells. The expansion was abolished in mice deficient for both <I>Ly49h</I> and <I>Prf1</I> (<I>Ly49h</I><sup>&ndash;/&ndash;</sup><I>Prf1</I><sup>&ndash;/&ndash;</sup>), and negative consequences for survival were revealed. The Ly49H-dependent protection mechanism delivered in the absence of <I>Prf1</I> was a result of interleukin 10 production, by the sustained NK cells, to regulate the magnitude of CD8 T cell responses. Thus, the studies demonstrate a previously unappreciated critical role for activating receptors in keeping NK cells present during viral infection to regulate adaptive immune responses.</p>
]]></description>
<dc:creator><![CDATA[Lee, S.-H., Kim, K.-S., Fodil-Cornu, N., Vidal, S. M., Biron, C. A.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082387</dc:identifier>
<dc:title><![CDATA[Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2235</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2251</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2235</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2253?rss=1">
<title><![CDATA[Self-class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2253?rss=1</link>
<description><![CDATA[
<p>Previous studies have suggested that naive CD8 T cells require self-peptide&ndash;major histocompatability complex (MHC) complexes for maintenance. However, interpretation of such studies is complicated because of the involvement of lymphopenic animals, as lymphopenia drastically alters naive T cell homeostasis and function. In this study, we explored naive CD8 T cell survival and function in nonlymphopenic conditions by using bone marrow chimeric donors and hosts in which class I MHC expression is absent or limited to radiosensitive versus radioresistant cells. We found that long-term survival of naive CD8 T cells (but not CD4 T cells) was impaired in the absence of class I MHC. However, distinct from this effect, class I MHC deprivation also enhanced naive CD8 T cell responsiveness to low-affinity (but not high-affinity) peptide&ndash;MHC ligands. We found that this improved sensitivity was a consequence of up-regulated CD8 levels, which was mediated through a transcriptional mechanism. Hence, our data suggest that, in a nonlymphopenic setting, self-class I MHC molecules support CD8 T cell survival, but that these interactions also attenuate naive T cell sensitivity by dynamic tuning of CD8 levels.</p>
]]></description>
<dc:creator><![CDATA[Takada, K., Jameson, S. C.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082553</dc:identifier>
<dc:title><![CDATA[Self-class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2253</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2269</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2253</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2271?rss=1">
<title><![CDATA[Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2271?rss=1</link>
<description><![CDATA[
<p>The <I>E2A</I> gene products, E12 and E47, are critical regulators of B cell development. However, it remains elusive whether E12 and E47 have overlapping and/or distinct functions during B lymphopoiesis. We have generated mice deficient for either E12 or E47 and examined their roles in B cell maturation. We show that E47 is essential for developmental progression at the prepro&ndash;B cell stage, whereas E12 is dispensable for early B cell development, commitment, and maintenance. In contrast, both E12 and E47 play critical roles in pre&ndash;B and immature B cells to promote immunoglobulin  (<I>Ig</I>) germline transcription as well as <I>Ig</I> VJ gene rearrangement. Furthermore, we show that E12 as well as E47 is required to promote receptor editing upon exposure to self-antigen. We demonstrate that increasing levels of E12 and E47 act to induce <I>Ig</I> germline transcription, promote trimethylated lysine 4 on histone 3 (H3) as well as H3 acetylation across the J region, and activate <I>Ig</I> VJ gene rearrangement. We propose that in the pre&ndash;B and immature B cell compartments, gradients of E12 and E47 activities are established to mechanistically regulate the sequential rearrangement of the Ig light chain genes.</p>
]]></description>
<dc:creator><![CDATA[Beck, K., Peak, M. M., Ota, T., Nemazee, D., Murre, C.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090756</dc:identifier>
<dc:title><![CDATA[Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2271</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2284</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2271</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/10/2285?rss=1">
<title><![CDATA[Nonaminoglycoside compounds induce readthrough of nonsense mutations]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/10/2285?rss=1</link>
<description><![CDATA[
<p>Large numbers of genetic disorders are caused by nonsense mutations for which compound-induced readthrough of premature termination codons (PTCs) might be exploited as a potential treatment strategy. We have successfully developed a sensitive and quantitative high-throughput screening (HTS) assay, protein transcription/translation (PTT)&ndash;enzyme-linked immunosorbent assay (ELISA), for identifying novel PTC-readthrough compounds using ataxia-telangiectasia (A-T) as a genetic disease model. This HTS PTT-ELISA assay is based on a coupled PTT that uses plasmid templates containing prototypic <I>A-T mutated</I> (<I>ATM</I>) mutations for HTS. The assay is luciferase independent. We screened ~34,000 compounds and identified 12 low-molecular-mass nonaminoglycosides with potential PTC-readthrough activity. From these, two leading compounds consistently induced functional ATM protein in ATM-deficient cells containing disease-causing nonsense mutations, as demonstrated by direct measurement of ATM protein, restored ATM kinase activity, and colony survival assays for cellular radiosensitivity. The two compounds also demonstrated readthrough activity in <I>mdx</I> mouse myotube cells carrying a nonsense mutation and induced significant amounts of dystrophin protein.</p>
]]></description>
<dc:creator><![CDATA[Du, L., Damoiseaux, R., Nahas, S., Gao, K., Hu, H., Pollard, J. M., Goldstine, J., Jung, M. E., Henning, S. M., Bertoni, C., Gatti, R. A.]]></dc:creator>
<dc:date>Mon, 28 Sep 2009 10:03:24 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20081940</dc:identifier>
<dc:title><![CDATA[Nonaminoglycoside compounds induce readthrough of nonsense mutations]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/10/2285</prism:object>
<prism:number>10</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2297</prism:endingPage>
<prism:publicationDate>2009-09-28</prism:publicationDate>
<prism:startingPage>2285</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1883?rss=1">
<title><![CDATA[Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1883?rss=1</link>
<description><![CDATA[
<p>The cause of Crohn's disease (CD) remains poorly understood. Counterintuitively, these patients possess an impaired acute inflammatory response, which could result in delayed clearance of bacteria penetrating the lining of the bowel and predispose to granuloma formation and chronicity. We tested this hypothesis in human subjects by monitoring responses to killed <I>Escherichia coli</I> injected subcutaneously into the forearm. Accumulation of <sup>111</sup>In-labeled neutrophils at these sites and clearance of <sup>32</sup>P-labeled bacteria from them were markedly impaired in CD. Locally increased blood flow and bacterial clearance were dependent on the numbers of bacteria injected. Secretion of proinflammatory cytokines by CD macrophages was grossly impaired in response to <I>E. coli</I> or specific Toll-like receptor agonists. Despite normal levels and stability of cytokine messenger RNA, intracellular levels of tumor necrosis factor (TNF) were abnormally low in CD macrophages. Coupled with reduced secretion, these findings indicate accelerated intracellular breakdown. Differential transcription profiles identified disease-specific genes, notably including those encoding proteins involved in vesicle trafficking. Intracellular destruction of TNF was decreased by inhibitors of lysosomal function. Together, our findings suggest that in CD macrophages, an abnormal proportion of cytokines are routed to lysosomes and degraded rather than being released through the normal secretory pathway.</p>
]]></description>
<dc:creator><![CDATA[Smith, A. M., Rahman, F. Z., Hayee, B., Graham, S. J., Marks, D. J.B., Sewell, G. W., Palmer, C. D., Wilde, J., Foxwell, B. M.J., Gloger, I. S., Sweeting, T., Marsh, M., Walker, A. P., Bloom, S. L., Segal, A. W.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20091233</dc:identifier>
<dc:title><![CDATA[Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1883</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>1897</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1883</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1899?rss=1">
<title><![CDATA[A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1899?rss=1</link>
<description><![CDATA[
<p>The innate immune system responds to unique molecular signatures that are widely conserved among microbes but that are not normally present in host cells. Compounds that stimulate innate immune pathways may be valuable in the design of novel adjuvants, vaccines, and other immunotherapeutics. The cyclic dinucleotide cyclic-di&ndash;guanosine monophosphate (c-di-GMP) is a recently appreciated second messenger that plays critical regulatory roles in many species of bacteria but is not produced by eukaryotic cells. In vivo and in vitro studies have previously suggested that c-di-GMP is a potent immunostimulatory compound recognized by mouse and human cells. We provide evidence that c-di-GMP is sensed in the cytosol of mammalian cells via a novel immunosurveillance pathway. The potency of cytosolic signaling induced by c-di-GMP is comparable to that induced by cytosolic delivery of DNA, and both nucleic acids induce a similar transcriptional profile, including triggering of type I interferons and coregulated genes via induction of TBK1, IRF3, nuclear factor B, and MAP kinases. However, the cytosolic pathway that senses c-di-GMP appears to be distinct from all known nucleic acid&ndash;sensing pathways. Our results suggest a novel mechanism by which host cells can induce an inflammatory response to a widely produced bacterial ligand.</p>
]]></description>
<dc:creator><![CDATA[McWhirter, S. M., Barbalat, R., Monroe, K. M., Fontana, M. F., Hyodo, M., Joncker, N. T., Ishii, K. J., Akira, S., Colonna, M., Chen, Z. J., Fitzgerald, K. A., Hayakawa, Y., Vance, R. E.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082874</dc:identifier>
<dc:title><![CDATA[A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1899</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>1911</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1899</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1913?rss=1">
<title><![CDATA[Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1913?rss=1</link>
<description><![CDATA[
<p>Recent publications have demonstrated the presence of tissue factor (TF)&ndash;bearing microparticles (MPs) in the blood of patients suffering from cancer. However, whether these MPs are involved in thrombosis remains unknown. We show that pancreatic and lung cancer cells produce MPs that express active TF and P-selectin glycoprotein ligand 1 (PSGL-1). Cancer cell&ndash;derived MPs aggregate platelets via a TF-dependent pathway. In vivo, cancer cell&ndash;derived MPs, but not their parent cells, infused into a living mouse accumulate at the site of injury and reduce tail bleeding time and the time to occlusion of venules and arterioles. This thrombotic state is also observed in mice developing tumors. In such mice, the amount of circulating platelet-, endothelial cell&ndash;, and cancer cell&ndash;derived MPs is increased. Endogenous cancer cell&ndash;derived MPs shed from the growing tumor are able to accumulate at the site of injury. Infusion of a blocking P-selectin antibody abolishes the thrombotic state observed after injection of MPs or in mice developing a tumor. Collectively, our results indicate that cancer cell&ndash;derived MPs bearing PSGL-1 and TF play a key role in thrombus formation in vivo. Targeting these MPs could be of clinical interest in the prevention of thrombosis and to limit formation of metastasis in cancer patients.</p>
]]></description>
<dc:creator><![CDATA[Thomas, G. M., Panicot-Dubois, L., Lacroix, R., Dignat-George, F., Lombardo, D., Dubois, C.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082297</dc:identifier>
<dc:title><![CDATA[Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1913</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>1927</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1913</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1929?rss=1">
<title><![CDATA[Decreased TNF-{alpha} synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1929?rss=1</link>
<description><![CDATA[
<p>Immunity declines during aging, however the mechanisms involved in this decline are not known. In this study, we show that cutaneous delayed type hypersensitivity (DTH) responses to recall antigens are significantly decreased in older individuals. However, this is not related to CC chemokine receptor 4, cutaneous lymphocyte-associated antigen, or CD11a expression by CD4<sup>+</sup> T cells or their physical capacity for migration. Instead, there is defective activation of dermal blood vessels in older subject that results from decreased TNF- secretion by macrophages. This prevents memory T cell entry into the skin after antigen challenge. However, isolated cutaneous macrophages from these subjects can be induced to secrete TNF- after stimulation with Toll-like receptor (TLR) 1/2 or TLR 4 ligands in vitro, indicating that the defect is reversible. The decreased conditioning of tissue microenvironments by macrophage-derived cytokines may therefore lead to defective immunosurveillance by memory T cells. This may be a predisposing factor for the development of malignancy and infection in the skin during aging.</p>
]]></description>
<dc:creator><![CDATA[Agius, E., Lacy, K. E., Vukmanovic-Stejic, M., Jagger, A. L., Papageorgiou, A.-P., Hall, S., Reed, J. R., Curnow, S. J., Fuentes-Duculan, J., Buckley, C. D., Salmon, M., Taams, L. S., Krueger, J., Greenwood, J., Klein, N., Rustin, M. H.A., Akbar, A. N.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090896</dc:identifier>
<dc:title><![CDATA[Decreased TNF-{alpha} synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1929</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>1940</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1929</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1941?rss=1">
<title><![CDATA[Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1941?rss=1</link>
<description><![CDATA[
<p>Allergen-specific desensitization is the only disease-modifying therapy currently available for the treatment of allergies. These therapies require application of allergen over several years and some may induce life-threatening anaphylactic reactions. An ideal vaccine for desensitization should be highly immunogenic and should alleviate allergic symptoms upon few injections while being nonreactogenic. We describe such a vaccine for the treatment of cat allergy, consisting of the major cat allergen Fel d1 coupled to bacteriophage Q&beta;-derived virus-like particles (Q&beta;&ndash;Fel d1). Q&beta;&ndash;Fel d1 was highly immunogenic, and a single vaccination was sufficient to induce protection against type I allergic reactions. Allergen-specific immunoglobulin G antibodies were shown to be the critical effector molecules and alleviated symptoms by two distinct mechanisms. Although allergen-induced systemic basophil degranulation was inhibited in an FcRIIb-dependent manner, inhibition of local mast cell degranulation in tissues occurred independently of FcRIIb. In addition, treatment with Q&beta;&ndash;Fel d1 abolished IgE memory responses upon antigen recall. Despite high immunogenicity, the vaccine was essentially nonreactogenic and vaccination induced neither local nor systemic anaphylactic reactions in sensitized mice. Moreover, Q&beta;&ndash;Fel d1 did not induce degranulation of basophils derived from human volunteers with cat allergies. These data suggest that vaccination with Q&beta;&ndash;Fel d1 may be a safe and effective treatment for cat allergy.</p>
]]></description>
<dc:creator><![CDATA[Schmitz, N., Dietmeier, K., Bauer, M., Maudrich, M., Utzinger, S., Muntwiler, S., Saudan, P., Bachmann, M. F.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090199</dc:identifier>
<dc:title><![CDATA[Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1941</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>1955</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1941</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1957?rss=1">
<title><![CDATA[Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1957?rss=1</link>
<description><![CDATA[
<p>FLT3-ITD&ndash;mediated leukemogenesis is associated with increased expression of oncogenic PIM serine/threonine kinases. To dissect their role in FLT3-ITD&ndash;mediated transformation, we performed bone marrow reconstitution assays. Unexpectedly, FLT3-ITD cells deficient for PIM1 failed to reconstitute lethally irradiated recipients, whereas lack of PIM2 induction did not interfere with FLT3-ITD&ndash;induced disease. PIM1-deficient bone marrow showed defects in homing and migration and displayed decreased surface CXCR4 expression and impaired CXCL12&ndash;CXCR4 signaling. Through small interfering RNA&ndash;mediated knockdown, chemical inhibition, expression of a dominant-negative mutant, and/or reexpression in knockout cells, we found PIM1 activity to be essential for proper CXCR4 surface expression and migration of cells toward a CXCL12 gradient. Purified PIM1 led to the phosphorylation of serine 339 in the CXCR4 intracellular domain in vitro, a site known to be essential for normal receptor recycling. In primary leukemic blasts, high levels of surface CXCR4 were associated with increased PIM1 expression, and this could be significantly reduced by a small molecule PIM inhibitor in some patients. Our data suggest that PIM1 activity is important for homing and migration of hematopoietic cells through modification of CXCR4. Because CXCR4 also regulates homing and maintenance of cancer stem cells, PIM1 inhibitors may exert their antitumor effects in part by interfering with interactions with the microenvironment.</p>
]]></description>
<dc:creator><![CDATA[Grundler, R., Brault, L., Gasser, C., Bullock, A. N., Dechow, T., Woetzel, S., Pogacic, V., Villa, A., Ehret, S., Berridge, G., Spoo, A., Dierks, C., Biondi, A., Knapp, S., Duyster, J., Schwaller, J.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082074</dc:identifier>
<dc:title><![CDATA[Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1957</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>1970</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1957</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1971?rss=1">
<title><![CDATA[Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1971?rss=1</link>
<description><![CDATA[
<p>Pathogens are sensed by Toll-like receptors (TLRs) expressed in leukocytes in the innate immune system. However, excess stimulation of TLR pathways is supposed to be connected with provocation of autoimmunity. We show that paired immunoglobulin (Ig)-like receptor B (PIR-B), an immunoreceptor tyrosine-based inhibitory motif&ndash;harboring receptor for major histocompatibility class I molecules, on relatively primitive B cells, B-1 cells, suppresses TLR9 signaling via Bruton's tyrosine kinase (Btk) dephosphorylation, which leads to attenuated activation of nuclear factor B p65RelA but not p38 or Erk, and blocks the production of natural IgM antibodies, including anti-IgG Fc autoantibodies, particularly rheumatoid factor. The autoantibody production in PIR-B&ndash;deficient (<I>Pirb</I><sup>&ndash;/&ndash;</sup>) mice was further augmented in combination with the <I>Fas<sup>lpr</sup></I> mutation, which might be linked to the development of autoimmune glomerulonephritis. These results show the critical link between TLR9-mediated sensing and a simultaneously evoked, PIR-B&ndash;mediated inhibitory circuit with a Btk intersection in B-1 cells, and suggest a novel way toward preventing pathogenic natural autoantibody production.</p>
]]></description>
<dc:creator><![CDATA[Kubo, T., Uchida, Y., Watanabe, Y., Abe, M., Nakamura, A., Ono, M., Akira, S., Takai, T.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082392</dc:identifier>
<dc:title><![CDATA[Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1971</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>1982</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1971</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1983?rss=1">
<title><![CDATA[Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1983?rss=1</link>
<description><![CDATA[
<p>Dendritic cell (DC) responses to extracellular self-DNA and self-RNA are prevented by the endosomal seclusion of nucleic acid&ndash;recognizing Toll-like receptors (TLRs). In psoriasis, however, plasmacytoid DCs (pDCs) sense self-DNA that is transported to endosomal TLR9 upon forming a complex with the antimicrobial peptide LL37. Whether LL37 also interacts with extracellular self-RNA and how this may contribute to DC activation in psoriasis is not known. Here, we report that LL37 can bind self-RNA released by dying cells, protect it from extracellular degradation, and transport it into endosomal compartments of DCs. In pDC, self-RNA&ndash;LL37 complexes activate TLR7 and, like self-DNA&ndash;LL37 complexes, trigger the secretion of IFN- without inducing maturation or the production of IL-6 and TNF-. In contrast to self-DNA&ndash;LL37 complexes, self-RNA&ndash;LL37 complexes also trigger the activation of classical myeloid DCs (mDCs). This occurs through TLR8 and leads to the production of TNF- and IL-6, and the differentiation of mDCs into mature DCs. We also found that self-RNA&ndash;LL37 complexes are present in psoriatic skin lesions and are associated with mature mDCs in vivo. Our results demonstrate that the cationic antimicrobial peptide LL37 converts self-RNA into a trigger of TLR7 and TLR8 in human DCs, and provide new insights into the mechanism that drives the auto-inflammatory responses in psoriasis.</p>
]]></description>
<dc:creator><![CDATA[Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F. J., Zal, T., Gilliet, M.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090480</dc:identifier>
<dc:title><![CDATA[Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1983</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>1994</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1983</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/1995?rss=1">
<title><![CDATA[A role for CD47 in the development of experimental colitis mediated by SIRP{alpha}+CD103- dendritic cells]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/1995?rss=1</link>
<description><![CDATA[
<p>Mesenteric lymph node (mLN) CD103 (E integrin)<sup>+</sup> dendritic cells (DCs) induce regulatory T cells and gut tolerance. However, the function of intestinal CD103<sup>&ndash;</sup> DCs remains to be clarified. CD47 is the ligand of signal regulatory protein  (SIRP) and promotes SIRP<sup>+</sup> myeloid cell migration. We first show that mucosal CD103<sup>&ndash;</sup> DCs selectively express SIRP and that their frequency was augmented in the lamina propria and mLNs of mice that developed Th17-biased colitis in response to trinitrobenzene sulfonic acid. In contrast, the percentage of SIRP<sup>+</sup>CD103<sup>&ndash;</sup> DCs and Th17 responses were decreased in CD47-deficient (CD47 knockout [KO]) mice, which remained protected from colitis. We next demonstrate that transferring wild-type (WT), but not CD47 KO, SIRP<sup>+</sup>CD103<sup>&ndash;</sup> DCs in CD47 KO mice elicited severe Th17-associated wasting disease. CD47 expression was required on the SIRP<sup>+</sup>CD103<sup>&ndash;</sup> DCs for efficient trafficking to mLNs in vivo, whereas it was dispensable on both DCs and T cells for Th17 polarization in vitro. Finally, administration of a CD47-Fc molecule resulted in reduced SIRP<sup>+</sup>CD103<sup>&ndash;</sup> DC&ndash;mediated Th17 responses and the protection of WT mice from colitis. We thus propose SIRP<sup>+</sup>CD103<sup>&ndash;</sup> DCs as a pathogenic DC subset that drives Th17-biased responses and colitis, and the CD47&ndash;SIRP axis as a potential therapeutic target for inflammatory bowel disease.</p>
]]></description>
<dc:creator><![CDATA[Fortin, G., Raymond, M., Van, V. Q., Rubio, M., Gautier, P., Sarfati, M., Franchimont, D.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082805</dc:identifier>
<dc:title><![CDATA[A role for CD47 in the development of experimental colitis mediated by SIRP{alpha}+CD103- dendritic cells]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/1995</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2011</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>1995</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/2013?rss=1">
<title><![CDATA[Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/2013?rss=1</link>
<description><![CDATA[
<p>The hypothesis that bystander inflammatory signals promote memory B cell (B<SUB>MEM</SUB>) self-renewal and differentiation in an antigen-independent manner is critically evaluated herein. To comprehensively address this hypothesis, a detailed analysis is presented examining the response profiles of B-2 lineage B220<sup>+</sup>IgG<sup>+</sup> B<SUB>MEM</SUB> toward cognate protein antigen in comparison to bystander inflammatory signals. After in vivo antigen encounter, quiescent B<SUB>MEM</SUB> clonally expand. Surprisingly, proliferating B<SUB>MEM</SUB> do not acquire germinal center (GC) B cell markers before generating daughter B<SUB>MEM</SUB> and differentiating into plasma cells or form structurally identifiable GCs. In striking contrast to cognate antigen, inflammatory stimuli, including Toll-like receptor agonists or bystander T cell activation, fail to induce even low levels of B<SUB>MEM</SUB> proliferation or differentiation in vivo. Under the extreme conditions of adjuvanted protein vaccination or acute viral infection, no detectable bystander proliferation or differentiation of B<SUB>MEM</SUB> occurred. The absence of a B<SUB>MEM</SUB> response to nonspecific inflammatory signals clearly shows that B<SUB>MEM</SUB> proliferation and differentiation is a process tightly controlled by the availability of cognate antigen.</p>
]]></description>
<dc:creator><![CDATA[Benson, M. J., Elgueta, R., Schpero, W., Molloy, M., Zhang, W., Usherwood, E., Noelle, R. J.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090667</dc:identifier>
<dc:title><![CDATA[Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/2013</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2025</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>2013</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/2027?rss=1">
<title><![CDATA[Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/2027?rss=1</link>
<description><![CDATA[
<p>Toll-like receptor (TLR) signals perform a crucial role in innate immune responses to pathogens. In this study, we found that the aryl hydrocarbon receptor (Ahr) negatively regulates inflammatory responses mediated by lipopolysaccharide (LPS) in macrophages. Ahr was induced in macrophages stimulated by LPS, but not by transforming growth factor (TGF)-&beta; plus interleukin (IL)-6, which can induce Ahr in naive T cells. The production of IL-6 and tumor necrosis factor (TNF)- by LPS was significantly elevated in Ahr-deficient macrophages compared with that in wild-type (WT) cells. Ahr-deficient mice were more highly sensitive to LPS-induced lethal shock than WT mice. Signal transducer and activator of transcription 1 (Stat1) deficiency, as well as Ahr deficiency, augmented LPS-induced IL-6 production. We found that Ahr forms a complex with Stat1 and nuclear factor-kappa B (NF-B) in macrophages stimulated by LPS, which leads to inhibition of the promoter activity of IL-6. Ahr thus plays an essential role in the negative regulation of the LPS signaling pathway through interaction with Stat1.</p>
]]></description>
<dc:creator><![CDATA[Kimura, A., Naka, T., Nakahama, T., Chinen, I., Masuda, K., Nohara, K., Fujii-Kuriyama, Y., Kishimoto, T.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20090560</dc:identifier>
<dc:title><![CDATA[Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/2027</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2035</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>2027</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jem.rupress.org/cgi/content/short/206/9/2037?rss=1">
<title><![CDATA[Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection]]></title>
<link>http://jem.rupress.org/cgi/content/short/206/9/2037?rss=1</link>
<description><![CDATA[
<p>Innate immune cells detect pathogens via pattern recognition receptors (PRRs), which signal for initiation of immune responses to infection. Studies with Dectin-1, a PRR for fungi, have defined a novel innate signaling pathway involving Syk kinase and the adaptor CARD9, which is critical for inducing Th17 responses to fungal infection. We show that another C-type lectin, Dectin-2, also signals via Syk and CARD9, and contributes to dendritic cell (DC) activation by fungal particles. Unlike Dectin-1, Dectin-2 couples to Syk indirectly, through association with the FcR chain. In a model of <I>Candida albicans</I> infection, blockade of Dectin-2 did not affect innate immune resistance but abrogated <I>Candida</I>-specific T cell production of IL-17 and, in combination with the absence of Dectin-1, decreased Th1 responses to the organism. Thus, Dectin-2 constitutes a major fungal PRR that can couple to the Syk&ndash;CARD9 innate signaling pathway to activate DCs and regulate adaptive immune responses to fungal infection.</p>
]]></description>
<dc:creator><![CDATA[Robinson, M. J., Osorio, F., Rosas, M., Freitas, R. P., Schweighoffer, E., Gross, O., Verbeek, J. S., Ruland, J., Tybulewicz, V., Brown, G. D., Moita, L. F., Taylor, P. R., Reis e Sousa, C.]]></dc:creator>
<dc:date>Mon, 31 Aug 2009 10:07:14 PDT</dc:date>
<dc:identifier>info:doi/10.1084/jem.20082818</dc:identifier>
<dc:title><![CDATA[Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection]]></dc:title>
<dc:publisher>The Rockefeller University Press</dc:publisher>
<prism:object>hw_mjid:jem;206/9/2037</prism:object>
<prism:number>9</prism:number>
<prism:volume>206</prism:volume>
<prism:endingPage>2051</prism:endingPage>
<prism:publicationDate>2009-08-31</prism:publicationDate>
<prism:startingPage>2037</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

</rdf:RDF>